Hyundai Bioscience Co., Ltd. (KOSDAQ:048410)
South Korea
· Delayed Price · Currency is KRW
5,710.00
-160.00 (-2.73%)
At close: Dec 5, 2025
Hyundai Bioscience Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 548,368 | 561,851 | 1,038,982 | 1,087,244 | 976,101 | 1,048,678 | |
| Market Cap Growth | -17.59% | -45.92% | -4.44% | 11.39% | -6.92% | 115.45% | |
| Enterprise Value | 519,009 | 579,143 | 1,031,571 | 1,069,527 | 969,321 | 1,050,097 | |
| Last Close Price | 5710.00 | 7055.00 | 12295.97 | 12908.41 | 11895.53 | 13756.41 | |
| PS Ratio | 279.74 | 37.33 | 109.58 | 138.48 | 105.62 | 83.82 | |
| PB Ratio | 4.97 | 14.25 | 22.95 | 18.67 | 15.85 | 20.04 | |
| P/TBV Ratio | 9.44 | 89.63 | 73.68 | 43.38 | 34.98 | 81.02 | |
| P/FCF Ratio | - | 269.15 | - | - | - | - | |
| P/OCF Ratio | - | 248.93 | - | - | - | 139.79 | |
| EV/Sales Ratio | 264.76 | 38.48 | 108.80 | 136.22 | 104.89 | 83.93 | |
| EV/EBITDA Ratio | - | 406.48 | - | - | - | - | |
| EV/EBIT Ratio | - | 732.19 | - | - | - | - | |
| EV/FCF Ratio | -14.66 | 277.44 | - | - | - | - | |
| Debt / Equity Ratio | 0.03 | 0.67 | 0.12 | 0.11 | 0.25 | 0.71 | |
| Debt / EBITDA Ratio | - | 18.66 | - | - | - | - | |
| Debt / FCF Ratio | - | 12.74 | - | - | - | - | |
| Asset Turnover | 0.02 | 0.25 | 0.16 | 0.11 | 0.11 | 0.16 | |
| Inventory Turnover | 1.44 | 1.78 | 1.62 | 1.63 | 1.59 | 1.19 | |
| Quick Ratio | 5.94 | 0.14 | 1.77 | 2.23 | 1.73 | 3.41 | |
| Current Ratio | 6.40 | 0.25 | 2.18 | 2.67 | 2.02 | 4.37 | |
| Return on Equity (ROE) | -28.52% | -16.36% | -28.02% | -26.39% | -35.21% | -16.50% | |
| Return on Assets (ROA) | -11.01% | 0.82% | -10.20% | -22.24% | -6.66% | -3.51% | |
| Return on Capital (ROIC) | -11.30% | 0.85% | -10.63% | -23.24% | -6.97% | -3.67% | |
| Return on Capital Employed (ROCE) | -14.90% | 2.00% | -21.40% | -45.10% | -14.70% | -5.30% | |
| Earnings Yield | -4.01% | -1.23% | -1.40% | -1.45% | -2.05% | -0.79% | |
| FCF Yield | -6.46% | 0.37% | -0.63% | -1.66% | -0.44% | -1.69% | |
| Buyback Yield / Dilution | -140.52% | -0.10% | -1.04% | -6.64% | -2.79% | -3.67% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.